Home Other Building Blocks Estropipate

Estropipate

CAS No.:
7280-37-7
Catalog Number:
AG003AXA
Molecular Formula:
C22H32N2O5S
Molecular Weight:
436.5649
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
≥98%
1 week
United States
$111
- +
10mg
99%
1 week
United States
$126
- +
50mg
99%
1 week
United States
$196
- +
100mg
99%
1 week
United States
$265
- +
500mg
99%
1 week
United States
$682
- +
Product Description
Catalog Number:
AG003AXA
Chemical Name:
Estropipate
CAS Number:
7280-37-7
Molecular Formula:
C22H32N2O5S
Molecular Weight:
436.5649
MDL Number:
MFCD00867399
IUPAC Name:
[(8R,9S,13S,14S)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate;piperazine
InChI:
InChI=1S/C18H22O5S.C4H10N2/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19;1-2-6-4-3-5-1/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22);5-6H,1-4H2/t14-,15-,16+,18+;/m1./s1
InChI Key:
HZEQBCVBILBTEP-ZFINNJDLSA-N
SMILES:
C1CNCCN1.O=C1CCC2C1(C)CCC1C2CCc2c1ccc(c2)OS(=O)(=O)O
EC Number:
230-696-3
UNII:
SVI38UY019
Properties
Complexity:
650  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
4  
Defined Bond Stereocenter Count:
0
Exact Mass:
436.203g/mol
Formal Charge:
0
Heavy Atom Count:
30  
Hydrogen Bond Acceptor Count:
7  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
436.567g/mol
Monoisotopic Mass:
436.203g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
113A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry research 20061030
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Hormone replacement therapy and cognition in an Australian representative sample aged 60-64 years. Maturitas 20060420
Generation and evaluation of a CYP2C9 heteroactivation pharmacophore. The Journal of pharmacology and experimental therapeutics 20031201
Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition. Canadian journal of physiology and pharmacology 20031001
A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density. Calcified tissue international 20030701
Estrogen replacement therapy in breast cancer survivors: a matched-controlled series. Menopause (New York, N.Y.) 20030101
Properties